Alex Kotzer
Plus aucun poste en cours
Profil
Mr. Alex Kotzer is Chairman & Chief Executive Officer at Regenera Pharma Ltd.
He is on the Board of Directors at Compugen Ltd.
He received his undergraduate degree from the Technion-Israel Institute of Technology.
Anciens postes connus de Alex Kotzer
| Sociétés | Poste | Fin |
|---|---|---|
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Directeur Général | - |
| COMPUGEN LTD. | President | 03/06/2009 |
Formation de Alex Kotzer
| Technion-Israel Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
